meitshel

SGMO - long -catalyst play

Long
meitshel Updated   
NASDAQ:SGMO   Sangamo Therapeutics, Inc.
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

This is not a financial advice!

Upcoming catalyst on 31st. of March

Keep an eye on 0.65 , 1.10 and 1.70 levels- needs to get broken for a further upmove.

SL under 0.3

TP approx. 2.8

Most info on the chart.

Trade carefully!
Comment:
i would say good timing
Comment:
fucking nailed it again! feel free to take gains if u want.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.